Two HCC cell lines, HepG2 and Huh-7, were treated with rocaglamide and/or TRAIL and the induction of apoptosis and effects on the TRAIL signaling pathway were investigated. This evidence concerns the gene TNFSF10 and hepatocellular carcinoma.